Tech Company Financing Transactions
Anacor Pharmaceuticals Funding Round
On 1/6/2009, Anacor Pharmaceuticals raised $50 million in funding from Aberdare Ventures, Care Capital and GlaxoSmithKline.
Transaction Overview
Company Name
Announced On
1/6/2009
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the financing will be used to further develop Anacor's product pipeline based on its boron chemistry platform.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1020 East Meadow Cir.
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Overview
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Berns
Chief Financial Officer
Geoffrey Parker
Chief Medical Officer
Lee Zane
VP - Bus. Development
Erik Wiberg
VP - Finance
James Marconi
VP - General Counsel
Ryan Sullivan
VP - Product Management
Kirk Maples
VP - R & D
Jacob Plattner
VP - Regulatory Affairs
Carmen Rodriguez
Browse more venture capital transactions:
Prev: 1/6/2009: RipCode venture capital transaction
Next: 1/6/2009: Entra Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs